MZ-242

CAS No. 1862238-01-4

MZ-242( MZ242 | MZ242 )

Catalog No. M12877 CAS No. 1862238-01-4

A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 963 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MZ-242
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.
  • Description
    A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM; displays no inhibitory activity against Sirt1 and Sirt 3 (IC50>100 uM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MZ242 | MZ242
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Sirtuin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1862238-01-4
  • Formula Weight
    525.646
  • Molecular Formula
    C24H27N7O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=NC=C(CC2=CC=CC(OCC3=CN(CCOC)N=N3)=C2)S1)CSC4=NC(C)=CC(C)=N4
  • Chemical Name
    2-((4,6-dimethylpyrimidin-2-yl)thio)-N-(5-(3-((1-(2-methoxyethyl)-1H-1,2,3-triazol-4-yl)methoxy)benzyl)thiazol-2-yl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Szabó A, et al. Sci Rep. 2017 Dec 6;7(1):17070. 2. Schiedel M, et al. Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6.
molnova catalog
related products
  • YK-3-237

    A novel small molecule sirtuin-1 (SIRT1) activator that reduces acetylation of mutant 53 and exhibits anti-proliferative effects against TNBC cells carrying mutant p53.

  • Salermide

    A potent Sirtuin inhibitor with IC50 of 76 and 45 uM for SIRT1 and SIRT2, respectively.

  • MC3482

    MC3482 is a potent, specific SIRT5 inhibitor, increases the ammonia content in cells leading to autophagy and mitophagy, shows selective SIRT5 inhibition vs SIRT1-3.